Hanmi Pharmaceutical Company Limited

This study tests a new medicine called HM11260C in adults with type 2 diabetes whose blood sugar is still too high despite taking metformin and dapagliflozin. About 118 people will receive either the new drug or a placebo for 36 weeks. The main goal is to see if the drug lowers H…

This early-phase study tests a new drug called BH3120, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. About 245 adults with PD…

This study tests a combination of two oral drugs, belvarafenib and cobimetinib, in people with advanced or spreading NRAS-mutant melanoma who have no good standard treatment left. About 45 adults will take the pills daily in 28-day cycles to see if tumors shrink or stop growing. …

This early-phase study tests an experimental drug called HM16390, alone or with another cancer drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. About 292 p…

This early-stage study is testing a new drug called HM17321 to see if it is safe and how the body processes it. About 90 healthy and obese adults will receive either the drug or a placebo. The main goal is to check for side effects, not to treat obesity yet.

This study tests an experimental drug called HM15912 (sonefpeglutide) in 18 adults with short bowel syndrome who need IV nutrition. The goal is to see if the drug is safe and can help the intestines absorb more nutrients, potentially reducing the need for IV support. Participants…